Yahoo Finance

Teva's Trisenox Gets FDA Approval as First-Line Treatment

Teva Pharmaceutical Industries Ltd. TEVA announced that the FDA has approved the label expansion of Trisenox injection to include first-line treatment of acute promyelocytic leukemia (“APL”) patients ...
Yahoo Finance

Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia

Teva Pharmaceutical Industries Ltd. TEVA announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended expanding Trisenox’s label in the EU ...
Pharmabiz

EMA panel recommends expansion of Teva's Trisenox for first line treatment of low- to intermediate risk APL

Teva Pharmaceutical Industries Ltd., announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending an ...
Cure Today

FDA Approves Trisenox Injection For Acute Promyelocytic Leukemia

The FDA approved a new combination for patients with newly-diagnosed low-risk acute promyelocytic leukemia (APL). The U.S. Food and Drug Administration (FDA) approved the combination use of Trisenox ...
The Financial

Teva Receives FDA Priority Review for First Line Use of TRISENOX

The FINANCIAL — Teva Pharmaceutical Industries Ltd. announced on September 12 the U.S. Food and Drug Administration (FDA) has accepted for review the company’s supplemental New Drug Application (sNDA) ...
Nasdaq

Teva's Trisenox Gets FDA Approval as First-Line Treatment

Teva Pharmaceutical Industries Ltd.TEVA announced that the FDA has approved the label expansion of Trisenox injection to include first-line treatment of acute promyelocytic leukemia ("APL") patients ...